ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $244,500 Qualifying Therapeutic Discovery Project grant from the Internal Revenue Service to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry bioassay [...]
Having peered into the high-tech future with confidence, Miller and the Adarza team — CEO Rand Henke and chief operating officer Terry Gronwall — now must deal with the timeless issues of the marketplace.
ROCHESTER, N.Y. – Adarza BioSystems, Inc. announced today that former Roche Molecular Systems CEO, Dr. Heiner Dreismann, an internationally recognized leader in the in vitro diagnostics industry, has joined Adarza’s Board of Directors. Dr. Dreismann [...]
ROCHESTER, NY: Adarza BioSystems, Inc. announced today that it has expanded its Board of Directors with the addition of two leading business executives: Dr. Heiner Dreismann, former CEO of Roche Molecular Systems and James Senall, [...]
Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program
NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO: The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds [...]
ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $245,912 Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company [...]
Life Science company expands presence to St. Louis ST. LOUIS, MO: BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, [...]
ROCHESTER, NY: Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 [...]
Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.
Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.
ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will [...]
ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the [...]
RiverVest leads $17 million investment in Adarza, brings on new president